Invention Grant
US09279118B2 Dimeric bacteriophage lysins 有权
二聚体噬菌体溶素

Dimeric bacteriophage lysins
Abstract:
The present invention provides isolated dimeric Streptococcus-specific phage lysins having two Streptococcus-specific phage lysin monomers covalently linked to each other, and having killing activity against one or more Streptococcus bacteria. Also provided for are pharmaceutical compositions of dimeric lysins and their use in therapeutic treatment or alleviation of infections or bacterial colonizations. The dimeric lysins may also be used to decontaminate porous and non-porous surfaces or devices.
Public/Granted literature
Information query
Patent Agency Ranking
0/0